Concepedia

Michael A. Damore

MA

Statistics

Publications

21

Citations

1.2K

H-Index

17

Active since

1992

Affiliations

Amgen (United States)(Current)

University of California, Los Angeles

Harvard University

Pfizer (United States)

Massachusetts General Hospital

Michael A. Damore is an author at Amgen (United States) specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

1992–2023

21

Publications

21

The Architecture and Evolution of Cancer Neochromosomes

Dale W. Garsed, Owen J. Marshall, Vincent Corbin et al. · Cancer Cell · 2014 · 199 citations · Full text

, , +5

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

Nizar J. Bahlis, Caitlin Costello, Noopur Raje et al. · Nature Medicine · 2023 · 122 citations · Full text

AID-Induced Genotoxic Stress Promotes B Cell Differentiation in the Germinal Center via ATM and LKB1 Signaling

Mara H. Sherman, Ali Kuraishy, Chetan Deshpande et al. · Molecular Cell · 2010 · 86 citations · Full text

, , +11

TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues

Michael A. Teitell, Michael A. Damore, G. Sulur et al. · Proceedings of the National Academy of Sciences · 1999 · 78 citations · Full text

Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti–Interferon‐γ Antibody, in Patients With Discoid Lupus Erythematosus

Victoria P. Werth, David Fiorentino, Barbara Sullivan et al. · Arthritis & Rheumatology · 2017 · 75 citations · Full text

1–5 of 21